Display options
Cite
Lemu LG, Woldu BF, Teke NE, et al. Precancerous Cervical Lesions Among HIV-Infected Women Attending HIV Care and Treatment Clinics in Southwest Ethiopia: A Cross-Sectional Study. Int J Womens Health. 2021;13:297-303doi: 10.2147/IJWH.S295137.
Lemu, L. G., Woldu, B. F., Teke, N. E., Bogale, N. D., & Wondimenew, E. A. (2021). Precancerous Cervical Lesions Among HIV-Infected Women Attending HIV Care and Treatment Clinics in Southwest Ethiopia: A Cross-Sectional Study. International journal of women's health, 13297-303. https://doi.org/10.2147/IJWH.S295137
Lemu, Lidiya Gutema, et al. "Precancerous Cervical Lesions Among HIV-Infected Women Attending HIV Care and Treatment Clinics in Southwest Ethiopia: A Cross-Sectional Study." International journal of women's health vol. 13 (2021): 297-303. doi: https://doi.org/10.2147/IJWH.S295137
Lemu LG, Woldu BF, Teke NE, Bogale ND, Wondimenew EA. Precancerous Cervical Lesions Among HIV-Infected Women Attending HIV Care and Treatment Clinics in Southwest Ethiopia: A Cross-Sectional Study. Int J Womens Health. 2021 Mar 03;13:297-303. doi: 10.2147/IJWH.S295137. eCollection 2021. PMID: 33688268; PMCID: PMC7937384.
Copy Download .nbib Format: NLM
Share it on

Int J Womens Health. 2021 Mar 03;13:297-303. doi: 10.2147/IJWH.S295137. eCollection 2021.

Precancerous Cervical Lesions Among HIV-Infected Women Attending HIV Care and Treatment Clinics in Southwest Ethiopia: A Cross-Sectional Study.

International journal of women's health

Lidiya Gutema Lemu, Biruktawit Fekade Woldu, Natnael Eshetu Teke, Nardos Delelegn Bogale, Ermias Ayalew Wondimenew

Affiliations

  1. Department of Midwifery, College of Health Science, Mizan Tepi University, Mizan-Aman, Ethiopia.
  2. Department of Midwifery, College of Medicine and Health Science, Wachemo University, Hossana, Ethiopia.
  3. Department of Midwifery, College of Medicine and Health Science, Wolkite University, Wolkite, Ethiopia.
  4. Department of Nursing, College of Health Science, Mizan Tepi University, Mizan-Aman, Ethiopia.

PMID: 33688268 PMCID: PMC7937384 DOI: 10.2147/IJWH.S295137

Abstract

BACKGROUND: Despite being one of the few cancers that can be prevented with simple testing, cervical cancer is the fourth most common cancer in women. HIV-positive women showed a median three-fold higher incidence of cervical lesions.

AIM: This study aims to assess the prevalence and factors associated with precancerous cervical lesions among HIV-infected women attending care and treatment clinic in selected hospitals of Southwestern Ethiopia.

METHODS: Institution-based cross-sectional study was conducted from February 1 to July 30, 2018. A systematic random sampling technique was employed to select 454 HIV-infected women. Pretested interviewer-administered questionnaire and medical record review were used for data collection. Visual inspection with Acetic acid was done for participants to detect precancerous cervical lesions. Data were analyzed by SPSS version 20. Binary and multiple logistic regression analyses were done. The presence and strength of association were determined using AOR with its 95% CI. Variables with a P value of less than 0.05 were considered as statistically significant.

RESULTS: The prevalence of precancerous cervical lesion was 18.7% [95% CI; (15.1-22.4%)]. Currently, not being on highly active antiretroviral treatment [AOR= 2.31, 95% CI: 1.23-4.39], age (20-29 years) [AOR= 0.185, 95% CI: 0.036,0.939], has no history of sexually transmitted infection [AOR=0.026, 95% CI: 0.006-0.116], has no history of genital wart [AOR= 0.261, 95% CI: 0.073-0.934] and having one lifetime sexual partner [AOR=0.133, 95% CI: 0.024-0.726] were found to be significantly associated with precancerous cervical lesion.

CONCLUSION: The prevalence of Precancerous Cervical lesion was found to be high in this study. Expansion of screening services and undertaking preventive measures against sexually transmitted infection need to be emphasized.

© 2021 Lemu et al.

Keywords: Ethiopia; HIV positive; factors; precancerous cervical lesion; prevalence

Conflict of interest statement

The authors declare that they have no conflicts of interest for this work.

References

  1. PLoS One. 2013 Dec 20;8(12):e84519 - PubMed
  2. Reprod Health Matters. 2008 Nov;16(32):41-9 - PubMed
  3. J Med Virol. 2017 Jun;89(6):1121-1124 - PubMed
  4. Arch Gynecol Obstet. 2014 Jun;289(6):1211-7 - PubMed
  5. Int J Health Sci (Qassim). 2019 May-Jun;13(3):4-9 - PubMed
  6. PLoS One. 2014 Mar 04;9(3):e90625 - PubMed
  7. Ethiop Med J. 2015 Jul;Suppl 2:17-24 - PubMed
  8. Glob Health Sci Pract. 2016 Mar 25;4(1):87-98 - PubMed
  9. AIDS. 2018 Mar 27;32(6):795-808 - PubMed
  10. Obstet Gynecol. 1997 Jan;89(1):76-80 - PubMed
  11. Infect Agent Cancer. 2013 Nov 15;8(1):45 - PubMed
  12. BMC Public Health. 2012 Mar 23;12:237 - PubMed
  13. CA Cancer J Clin. 2018 Nov;68(6):394-424 - PubMed
  14. Int J STD AIDS. 2014 Mar;25(3):163-77 - PubMed
  15. Pan Afr Med J. 2015 Sep 11;22:26 - PubMed
  16. AIDS Res Treat. 2012;2012:953743 - PubMed
  17. J Oncol. 2016;2016:5473681 - PubMed
  18. East Afr J Public Health. 2011 Sep;8(3):185-9 - PubMed
  19. Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1434-8 - PubMed
  20. Int J Gynecol Cancer. 2010 Oct;20(7):1244-9 - PubMed
  21. Afr Health Sci. 2019 Mar;19(1):1695-1704 - PubMed
  22. Reprod Sci. 2013 Dec 13;21(7):837-845 - PubMed
  23. Med Sci Monit. 2016 Jun 01;22:1858-65 - PubMed

Publication Types